Harmony Biosciences Files 8-K
Ticker: HRMY · Form: 8-K · Filed: Jun 11, 2025 · CIK: 1802665
| Field | Detail |
|---|---|
| Company | Harmony Biosciences Holdings, INC. (HRMY) |
| Form Type | 8-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: HRMY
TL;DR
Harmony Biosciences filed a routine 8-K on 6/11/25. No major news, just compliance.
AI Summary
Harmony Biosciences Holdings, Inc. filed an 8-K on June 11, 2025, reporting on Regulation FD disclosures and financial statements. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Harmony Biosciences is meeting its regulatory reporting obligations. Investors should review the full document for any specific disclosures that may impact the company's operations or financial standing.
Risk Assessment
Risk Level: low — This is a standard regulatory filing with no new material information or significant financial events disclosed.
Key Players & Entities
- Harmony Biosciences Holdings, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of report
- 0001558370-25-008525 (filing_id) — Accession Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Regulation FD disclosures and to include financial statements and exhibits as required by the SEC.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is June 11, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462.
What is the registrant's telephone number?
The registrant's telephone number, including area code, is (484) 539-9800.
What is the Standard Industrial Classification code for Harmony Biosciences Holdings, Inc.?
The Standard Industrial Classification code for Harmony Biosciences Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 11, 2025 regarding Harmony Biosciences Holdings, Inc. (HRMY).